Nootropics Index - Save on smarter supplements
Nootropics>Hormones & endocrine-related compounds>Melatonin
Hormones & endocrine-related compounds

Melatonin

N-acetyl-5-methoxytryptamine

Melatonin is an endogenous sleep-timing hormone sold in several delivery formats. The best evidence is for selected circadian timing contexts, not general nootropic or productivity enhancement. For comparison, focus on delivery form, labeled amount per serving, form-specific price units, next-day drowsiness, interaction context, gummy-label accuracy findings, and the distinct U.S. and U.K. regulatory contexts described on this page.

Sleep SupportHormone SupportHormonal Axis RelatedClinical ResearchSleep HygieneModerate Human EvidencePopulation Specific Evidence
Updated August 2026/6 min read/10 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What melatonin is

1

Melatonin is an endogenous hormone involved in circadian sleep-wake timing.

02

Names, aliases and forms

Common NamesMelatonin; sleep hormone
Scientific NameN-acetyl-5-methoxytryptamine
Spelling Variantmelatonine
03

Mechanisms of action

Sleep timing is the core mechanism

2

Melatonin signals biological night and can shift circadian timing when used at the right time. That differs from using it as a stronger sedative or a cognitive enhancer; the timing of use often matters as much as the milligram amount.

04

Potential effects and evidence map

Melatonin has a clearer evidence base for selected circadian rhythm timing contexts than for broad chronic-insomnia use or cognitive enhancement. AASM guidance supports strategically timed melatonin in selected circadian sleep-wake rhythm disorders, while adult chronic-insomnia guidance does not support it as a broad default. Buyer comparisons should distinguish form-specific price units from a cross-form value ranking, and prioritize the labeled amount per serving, gummy-label accuracy findings and individual safety context over marketing strength.

Effect domainMagnitudeGrade
Sleep quality2
AcuteConfidence: Medium

Melatonin is most evidence-relevant as a sleep-timing aid in selected circadian contexts, not as a general-purpose sleep claim.

Note AASM circadian guideline supports selected, timed use.

3/5
B
Calm / relaxation1
AcuteConfidence: Medium

Relaxation or calm claims are indirect and should not replace sleep-timing framing.

Note Sedation is a safety effect, not a nootropic benefit.

1/5
D
Focus / attention2
UnknownConfidence: High

Direct focus or productivity outcomes are not assessed by the cited sleep-timing sources; this profile does not present a focus benefit.

Note No direct focus or productivity outcome is cited in this sleep-timing profile.

0/5
E
Memory / learning2
UnknownConfidence: High

Direct memory or learning outcomes are not assessed by the cited sleep-timing sources; this profile does not present a memory benefit.

Note No direct memory or learning outcome is cited in this sleep-timing profile.

0/5
E
05

Typical dosages and timing

Product label9Per serving

For U.S. dietary supplements, the Supplement Facts label identifies serving size, servings per container, dietary ingredients and their listed amount per serving. Those fields describe an individual product; they are not a recommended melatonin dose.

06

Timing & effect horizon

Effect horizonAcute
Acute
No profile-wide timing schedule1

The cited sleep-timing research is indication- and population-specific. NCCIH describes a 4-week delayed sleep-wake phase disorder study in which melatonin was taken 1 hour before the desired bedtime alongside a consistent bedtime. That study does not establish a generic retail-product schedule or use cycle.

07

Safety, side effects and risk profile

Possible short-term effects1
NCCIH reports that short-term studies have mainly described mild effects such as sleepiness, headache, dizziness and nausea. Practical impairment can matter when drowsiness would be hazardous.
Child-safety storage matters5
CDC U.S. poison-center surveillance recorded a large increase in reported melatonin ingestions among children from 2012 to 2021. Keep products secured around children.
High labeled amounts and bulk powders add uncertainty1
NCCIH says there is not enough safety information to give a clear overall picture for melatonin supplements, particularly at doses higher than the body normally produces. That uncertainty is relevant when comparing high labeled amounts; a bulk-powder package size alone does not establish the amount being used.
Older-adult context1
NCCIH notes that melatonin may remain active longer in older people and cause daytime drowsiness; it also notes 2015 AASM guidance against melatonin use in people with dementia.
Gummy content may differ from label4
A 2023 U.S. study found that many melatonin gummy products did not match their stated melatonin amount. Compare labels, but do not assume the printed milligrams precisely equal the amount delivered.
Sedation / impairment1
Confidence: High

Sleepiness and next-day drowsiness are practical concerns when drowsiness would be hazardous.

Note Short-term adult studies mainly report mild effects; use context can change the practical risk.

2/5
B
Interaction risk1
Confidence: High

Medication interaction contexts need extra caution.

Note NCCIH highlights epilepsy and blood-thinner medication contexts.

2/5
B
Pregnancy / lactation caution1
Confidence: Medium

Safety evidence in pregnancy and lactation is limited.

Note Keep this as a special-population caution rather than a healthy-adult base-risk signal.

2/5
C
Hormonal caution1
Confidence: Medium

Pediatric and endocrine contexts have important evidence gaps.

Note NCCIH notes uncertainty around hormonal development with supplement use in children.

2/5
C
Headache / dizziness1
Confidence: High

Headache, dizziness, nausea and daytime sleepiness are practical adverse-effect categories.

Note Summarize as common tolerability issues.

2/5
B
Legal / regulatory risk7
Confidence: High

Access and product classification differ between jurisdictions.

Note A buyer should check the destination market instead of inferring international availability from U.S. listings.

1/5
B
Evidence uncertainty3
Confidence: High

Evidence is clearer for selected timing contexts than broad sleep or nootropic claims.

Note Keep cognition, long-term use and broad chronic-insomnia claims conservative.

2/5
B
08

Interactions and cautions

Interaction check1

NCCIH identifies epilepsy and blood-thinner medication contexts as ones that need medical supervision with melatonin supplements.

09

Legal and regulatory status

United States8

As checked in 2026, U.S. dietary supplements are not FDA-approved for safety or effectiveness before sale. This regulatory status does not establish that a particular melatonin product is appropriate or accurately labeled.

United Kingdom10

In an August 2025 notice, MHRA stated that melatonin is authorised for use in the United Kingdom as a prescription medicine for specific sleep disorders. This statement is limited to United Kingdom status and does not establish access or import rules elsewhere.

10

Practical buying and quality notes

  • The offer table normalizes powder by gram and capsules by capsule. Those form-specific units are not a cross-form best-price ranking. Use each product label for serving information when comparing products within a form.9
  • A 2023 U.S. study found that many tested melatonin gummy products did not match their stated melatonin amount. That finding does not mean every product label is inaccurate.4
11

FAQ

Is melatonin a nootropic?

2

Not as a direct focus, memory or productivity enhancer. It is best understood as a sleep-timing hormone; better sleep timing may indirectly matter, but that is not the same as a cognitive-enhancement claim.

Does a label amount equal a studied dose?

9

No. A Supplement Facts label provides product serving information, while studies use specific populations, indications, timing and durations. This profile does not convert a label amount into a generic melatonin dose.

Can melatonin be used every night long term?

1

NCCIH says short-term melatonin appears safe for most adults, while long-term safety is not known. Its safety discussion identifies additional considerations for children, pregnancy or breastfeeding, and people with epilepsy or blood-thinner use.

What does the timing research show?

1

NCCIH describes a 4-week delayed sleep-wake phase disorder study that used melatonin 1 hour before the desired bedtime with a consistent bedtime. It is study context, not a schedule for every melatonin product or situation.

What is the United Kingdom status?

10

The cited August 2025 MHRA notice states that authorised melatonin use in the United Kingdom is prescription-medicine use for specific sleep disorders. This statement is UK-specific; the page does not infer legal or import status elsewhere.

Can powder and capsule prices be compared directly?

9

Not as a single best-price ranking. This page normalizes powder by gram and capsules by capsule, so compare like with like and use each product label for serving information.

12

References

  1. National Center for Complementary and Integrative Health. Melatonin: What You Need To Know.
  2. Auger RR, et al. AASM clinical practice guideline for intrinsic circadian rhythm sleep-wake disorders. J Clin Sleep Med. 2015.
  3. Sateia MJ, et al. AASM clinical practice guideline for pharmacologic treatment of chronic insomnia in adults. J Clin Sleep Med. 2017.
  4. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023.
  5. CDC MMWR. Pediatric Melatonin Ingestions - United States, 2012-2021.
  6. Erland LAE, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med. 2017.
  7. NHS. Melatonin: about melatonin.
  8. U.S. Food and Drug Administration. Information for Consumers on Using Dietary Supplements.
  9. U.S. Food and Drug Administration. FDA 101: Dietary Supplements.
  10. Medicines and Healthcare products Regulatory Agency. UK statement on undeclared melatonin in childrens magnesium gummies.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.